Evidence map›Paper›PMID 32144888›Full record

ArticleJournal of the International AIDS Society2020

"I just believe there is a risk" understanding of undetectable equals untransmissible (U = U) among health providers and HIV-negative partners in serodiscordant relationships in Kenya.

Kenneth Ngure, Fernandos Ongolly, Annabell Dolla, Merceline Awour, Kenneth K Mugwanya, Elizabeth Irungu, Nelly Mugo, Elizabeth A Bukusi, Jennifer Morton, Josephine Odoyo and 6 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 3 pooled it
0.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 3 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Kenneth NgureDepartment of Community Health, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.ORCID 0000-0002-8062-0933
Fernandos OngollyCenter for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Annabell DollaCenter for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Merceline AwourCenter for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Kenneth K MugwanyaDepartment of Global Health, University of Washington, Seattle, WA, USA.
Elizabeth IrunguDepartment of Community Health, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.
Nelly MugoDepartment of Global Health, University of Washington, Seattle, WA, USA.
Elizabeth A BukusiDepartment of Global Health, University of Washington, Seattle, WA, USA.
Jennifer MortonDepartment of Global Health, University of Washington, Seattle, WA, USA.
Josephine OdoyoCenter for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Elizabeth WamoniCenter for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Gena BarnabeeDepartment of Global Health, University of Washington, Seattle, WA, USA.
Kathryn PeeblesDepartment of Epidemiology, University of Washington, Seattle, WA, USA.
Gabrielle O'MalleyDepartment of Global Health, University of Washington, Seattle, WA, USA.
Jared M BaetenDepartment of Global Health, University of Washington, Seattle, WA, USA.ORCID 0000-0001-8242-8438
Partners Scale-Up Project Team
University of Washington · USKenya Medical Research Institute · KEJomo Kenyatta University of Agriculture and Technology · KE

Funding

Optimizing Antiretroviral-Based HIV Prevention for HIV Serodiscordant CouplesR01MH095507 · NIMH · UNIVERSITY OF WASHINGTON · PI BAETEN, JARED · 2011 to 2020
$6.1M
A differentiated care model to improve the efficiency of PrEP delivery in KenyaR00MH118134 · NIMH · UNIVERSITY OF WASHINGTON · PI MUGWANYA, KENNETH KIGGUNDU · 2019 to 2021
$743k
A differentiated care model to improve the efficiency of PrEP delivery in KenyaK99MH118134 · NIMH · UNIVERSITY OF WASHINGTON · PI MUGWANYA, KENNETH KIGGUNDU · 2018 to 2018
$123k
NIMH NIH HHS K99 MH118134NIMH NIH HHS R00 MH118134NIMH NIH HHS R01 MH095507
6 · The paper itself

Abstract

introductionSustained HIV viral suppression resulting from antiretroviral therapy (ART) eliminates the risk of HIV transmission, a concept popularly framed as Undetectable = Untransmittable (U = U). We explored knowledge and acceptance of information around the elimination of HIV transmission risk with ART (U = U) in Kenya.

methodsOur qualitative study was conducted within a project evaluating the use of pre-exposure prophylaxis (PrEP) integrated into ART care for HIV serodiscordant couples in public clinics in Kenya (the Partners Scale Up Project). From February 2017 to April 2019, we conducted semi-structured key informant interviews with 83 health providers and in-depth interviews with 61 HIV-negative people in serodiscordant relationships receiving PrEP services. Transcripts were coded using thematic analysis.

resultsHealth providers reported being aware of reduced risk of HIV transmission as a result of consistent ART use and used words such as "very low," "minimal" and "like zero" to describe HIV transmission risk after viral suppression. Providers reported finding viral load results helpful when counselling clients about the risk of HIV transmission. Many lacked confidence in U = U and counselled on consistent condom use even after viral suppression while some expressed concerns that communicating this message to people living with HIV (PLHIV) would lead them to engage in multiple sexual relationships. Other providers reported that they did not counsel about the reduced risk of HIV transmission after viral suppression for fear of being blamed if HIV transmission occurred. HIV-negative partners reported being informed about U = U by providers but they did not believe nor trust the message. Even after their partners achieved viral suppression, some HIV-negative partners were unwilling to stop PrEP, while others indicated that they would use condoms if they stopped PrEP to be sure that they were protected from HIV.

conclusionsDespite awareness that effective ART use eliminates HIV transmission risk, there is both a lack of in-depth knowledge and conviction about the strategy among health providers and HIV-negative partners in serodiscordant relationships. New strategies that go beyond communicating the science of U = U to consider the local social and clinical environments could maximize the effectiveness of U = U.

Indexed as

Health PersonnelPre-Exposure ProphylaxisSexual PartnersAdultAnti-HIV AgentsCondomsCounselingFemaleHealth Knowledge, Attitudes, PracticeHIV InfectionsHumansKenyaMaleMiddle AgedRisk AssessmentRisk Reduction BehaviorAnti-HIV AgentsARTHIV serodiscordant couplesHIV viral suppressionKenyaPrEPrisktreatment as prevention

Identifiers

PMID32144888
PMCPMC7060133
OpenAlexW3009438983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.